Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Market: NASD |
Currency: USD
Address: 500 River Ridge Drive
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.
Show more
📈 Corbus Pharmaceuticals Holdings, Inc. Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$42.89
-
Upside/Downside from Analyst Target:
416.11%
-
Broker Call:
20
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
25-50%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
-
💰 Dividend History
| Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
| 2023 |
- |
$0.033333 |
- |
2023-02-14 |
- |
Stock split |
|
Total Amount for 2023: $0.033333 |
📅 Earnings & EPS History for Corbus Pharmaceuticals Holdings, Inc.
| Date | Reported EPS |
|---|
| 2026-05-04 (estimated upcoming) | - |
| 2026-03-09 (estimated upcoming) | - |
| 2025-11-05 (estimated upcoming) | - |
| 2025-11-04 (estimated upcoming) | - |
| 2025-08-04 (estimated upcoming) | - |
| 2025-08-03 (estimated upcoming) | - |
| 2025-05-06 | -1.39 |
| 2025-05-05 | - |
| 2025-05-04 | - |
| 2025-03-11 | -0.78 |
| 2025-03-09 | - |
| 2024-11-07 | -1.15 |
| 2024-08-06 | -0.9 |
| 2024-08-05 | -0.9 |
| 2024-05-07 | -0.83 |
| 2024-05-06 | -0.83 |
| 2024-03-12 | -1.81 |
| 2024-03-11 | -1.81 |
| 2023-11-07 | -2.05 |
| 2023-11-06 | -2.05 |
| 2023-08-08 | -2.05 |
| 2023-08-07 | -2.05 |
| 2023-05-09 | -4.24 |
| 2023-05-08 | -4.24 |
| 2023-03-07 | -2.61 |
| 2023-03-06 | -2.61 |
| 2022-11-08 | -2.1 |
| 2022-11-07 | -2.1 |
| 2022-08-09 | -3.3 |
| 2022-08-08 | -3.3 |
| 2022-05-10 | -2.4 |
| 2022-05-09 | -2.4 |
| 2022-03-08 | -2.4 |
| 2022-03-07 | -2.4 |
| 2021-11-12 | -0.6 |
| 2021-11-11 | -0.6 |
| 2021-08-12 | -4.5 |
| 2021-08-11 | -4.5 |
| 2021-05-13 | -4.2 |
| 2021-05-12 | -4.2 |
| 2021-03-15 | -3 |
| 2021-03-14 | -3 |
| 2020-11-09 | -12.6 |
| 2020-11-08 | -12.6 |
| 2020-08-06 | -15.6 |
| 2020-08-05 | -15.6 |
| 2020-05-11 | -12.9 |
| 2020-05-10 | -12.9 |
| 2020-03-12 | -12.3 |
| 2020-03-11 | -12.3 |
| 2019-11-06 | -9.6 |
| 2019-08-07 | 0.9 |
| 2019-05-08 | -12.9 |
| 2019-03-11 | -9 |
| 2018-11-07 | -7.8 |
| 2018-08-07 | -6.3 |
| 2018-05-09 | -6.3 |
| 2018-03-11 | -6.3 |
| 2017-11-07 | -4.2 |
| 2017-08-08 | -4.5 |
| 2017-05-08 | -4.8 |
| 2017-03-07 | -5.4 |
| 2016-11-09 | -3.6 |
| 2016-08-11 | -3.3 |
| 2016-05-12 | -2.4 |
| 2016-03-27 | -1.8 |
| 2015-11-10 | -1.8 |
| 2015-08-12 | - |
| 2015-05-12 | - |
| 2015-02-09 | - |
| 2014-11-13 | - |
| 2014-10-27 | - |
📰 Related News & Research
No related articles found for "corbus pharmaceuticals".
